过去一年中添加的文章,按日期排序

New and future therapies: Changes in the therapeutic armamentarium for SLE

A Askanase, L Khalili, W Tang, P Mertz… - Best Practice & …, 2023 - Elsevier
300 天前 - … treatment as well as of the most promising potential future therapeutic strategies
in SLE. … for SLE treatment, with various targets including inflammatory cytokines and their …

Two for one? CAR-T therapy for lymphoma benefits concurrent autoimmune disorders

V Bachanova, PH Nachman - Bone marrow transplantation, 2023 - nature.com
306 天前 - … Immune effector associated events such as cytokine release … CD19-CAR T cell
therapy with a 4-1BB co-stimulatory … of five patients with severe, refractory SLE. The safety data …

[HTML][HTML] The changes of Treg and Th17 cells relate to serum 25 (OH) D in patients with initial-onset childhood systemic lupus erythematosus

L Jiang, Z Rong, H Zhang - Frontiers in Pediatrics, 2023 - ncbi.nlm.nih.gov
318 天前 - systemic lupus erythematosus (SLE). Improving the balance between Treg and Th17
cells can be a promising new therapeutic target in SLE … Th17, Treg, cytokines, and serum …

Clinical research progress of novel biologics for the treatment of lupus nephritis

W Cui, Y Tian, G Huang, X Zhang, F Li, X Liu - Clinical and Experimental …, 2023 - Springer
333 天前 - Systemic lupus erythematosus (SLE) is a chronic … such as immune cells, cytokines,
and immune complex … Therefore, type I IFN is expected to be the therapeutic target for LN. …

[HTML][HTML] Role of IL-2/IL-2 receptor in pathogenesis of autoimmune disorders: Genetic and therapeutic aspects

S Rafaqat, S Rafaqat - World Journal of Medical Genetics, 2023 - wjgnet.com
336 天前 - … The focus of this review is on systemic lupus erythematosus, rheumatoid … cytokine
profiles of SLE patients and found that peripheral blood mononuclear cells (PBMCs) from SLE

The Oxysterol Receptor EBI2 Links Innate and Adaptive Immunity to Limit IFN Response and Systemic Lupus Erythematosus

F Zhang, B Zhang, H Ding, X Li, X Wang… - Advanced …, 2023 - Wiley Online Library
336 天前 - … potential diagnostic marker and therapeutic target for SLE. … As cytokines secreted
by activated immune cells such as … of SLE, we treated PEMs with various cytokines and …

cAMP responsive element modulator α promotes effector T cells in systemic autoimmune diseases

E Carlsson, T Cowell‐McGlory, CM Hedrich - Immunology, 2023 - Wiley Online Library
343 天前 - … Dysregulation of T cell-derived inflammatory cytokine … diseases, including
systemic lupus erythematosus (SLE) and … candidate and/or therapeutic target in effector T cell …

The developing role of extracellular vesicles in autoimmune diseases: special attention to mesenchymal stem cell-derived extracellular vesicles

GGR Ortiz, NH Zaidi, RS Saini, AAR Coronel… - International …, 2023 - Elsevier
345 天前 - … diseases do not depend on direct intercellular communication but on their ability
to release a wide spectrum of paracrine mediators such as growth factors, cytokines and …

Role of Th17 and IL-17 Cytokines on Inflammatory and Auto-immune Diseases

S Akhter, FM Tasnin, MN Islam, A Rauf… - Current …, 2023 - ingentaconnect.com
355 天前 - … as therapeutic targets. Current treatments utilizing antibodies against IL-17 cytokines
and … SLEDAI (systemic lupus erythematosus Disease activity index) score in patients of this …

Differential expression of IFN-α, IL-12 and BAFF on renal immune cells and its relevance to disease activity and treatment responsiveness in patients with proliferative …

A Nawata, S Nakayamada, S Hisano… - Lupus Science & …, 2023 - lupus.bmj.com
355 天前 - SLE, IFN-α secreted by plasmacytoid dendritic cells is considered the most important
cytokine … The IHC study of therapeutic target markers for precision medicine is technically …